Zobrazeno 1 - 10
of 127
pro vyhledávání: '"S A Schreiber"'
Autor:
B E Sands, D T Rubin, J Panés, K B Gecse, Y Leung, M Goetsch, W Wang, K Shan, J Woolcott, C C Smith, K Wosik, S W Schreiber
Publikováno v:
Journal of Crohn's and Colitis. 17:i106-i107
Background Achievement of corticosteroid (CS)-free remission is an important long-term outcome in ulcerative colitis (UC). Etrasimod is an investigational, once-daily, oral, selective sphingosine 1-phosphate receptor 1,4,5 (S1P1,4,5) modulator in dev
Publikováno v:
Journal of Crohn's and Colitis. 17:i485-i486
Background Clinical understanding of different disease courses in response to targeted therapies in ulcerative colitis (UC) is lacking. Symptom load over time can help to define different trajectories leading to outcome measures at week 52. This post
Autor:
S W Schreiber, S Danese, A Dignass, E Domènech, M Fantini, M Ferrante, J Halfvarson, A Hart, F Magro, C Lees, S Leone, M Pierik, P Field, H Schofield, L Peyrin-Biroulet
Publikováno v:
Journal of Crohn's and Colitis. 17:i311-i312
Background Real-world treatment of ulcerative colitis (UC) requires a patient-centric, holistic definition of ‘comprehensive remission' that goes beyond standard regulatory definitions. In an international initiative, we reviewed aspects of UC that
Autor:
J Hsieh, Gerhard Rogler, Edward V. Loftus, Y Zhou, U Moerch, S Zhao, S W Schreiber, C Yun, Mamoru Watanabe
Publikováno v:
Journal of Crohn's and Colitis. 15:S004-S006
Background Filgotinib (FIL) is an oral preferential Janus kinase (JAK) 1 inhibitor in development for the treatment of inflammatory diseases. FIL for the treatment of moderately to severely active ulcerative colitis (UC) was evaluated in the phase 2b
Publikováno v:
Ultrasound International Open, Vol 01, Iss 02, Pp E53-E57 (2015)
Purpose: To differentiate PCA segments and cortical branches by means of transcranial color-coded duplex sonography (TCCD) and to measure flow parameters at rest and during visual stimulation. Materials and Methods: 60 healthy subjects with a good a
Externí odkaz:
https://doaj.org/article/28c4d57815c349059f4440bb514044e9
Autor:
G Akhundova-Unadkat, L Peyrin-Biroulet, Severine Vermeire, Bruce E. Sands, Michael Chiorean, CJ Rabbat, J Panés, S W Schreiber, Snehal Naik, W J Sandborn
Publikováno v:
Viszeralmedizin 2021 Gemeinsame Jahrestagung Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), Sektion Endoskopie der DGVS, Deutsche Gesellschaft für Allgemein und Viszeralchirurgie (DGAV).
Autor:
S W Schreiber, R Cross, R Panaccione, G D’Haens, P Bossuyt, J F Colombel, E Louis, M Dubinsky, K Kligys, E Neimark, A Song, J Zambrano, E Cheng, M Ferrante
Publikováno v:
Journal of Crohn's and Colitis. 16:i125-i126
Background The efficacy and safety of risankizumab (RZB) as induction and maintenance therapy for patients with moderately to severely active Crohn’s disease (CD) has been documented. Steroid-free clinical remission is an important additional treat
Autor:
Sofie Berg, Ezequiel Neimark, Xiaomei Liao, Marc Ferrante, James O. Lindsay, S W Schreiber, A P Song, W J Sandborn, T Feng, Tadakazu Hisamatsu, David T. Rubin, Kori Wallace, J.-F. Colombel, Remo Panaccione, G R D’Haens, A Lim
Publikováno v:
Journal of Crohn's and Colitis. 15:S026-S027
Background Present therapies leave an unmet need for early and effective treatment for patients with Crohn’s disease (CD). Risankizumab (RZB), a humanized immunoglobulin G1 monoclonal antibody against the p19 subunit of interleukin-23, was evaluate
Publikováno v:
Sustainability, Vol 10, Iss 12, p 4710 (2018)
Sustainability
Volume 10
Issue 12
Sustainability
Volume 10
Issue 12
The stormwater runoff that carries pollutants from the land adjacent to road transportation systems may impair the water environment and threaten the ecosystem and human health. A proper management approach like green stormwater infrastructure (GSI)
Autor:
Erasmo Benício Santos de Moraes Trindade, Bruna Teles Soares Beserra, Tânia Silvia Fröde, Ricardo Fernandes, Julia Salvan da Rosa, Rafaella Cristina Dimbarre de Miranda, Michel Carlos Mocellin, Marilyn G.F. Kuntz, Cristina S. O. Schreiber, Everson Araújo Nunes
Publikováno v:
Journal of Clinical Gastroenterology. 50:208-217
Background Studies have shown that prebiotics and synbiotics modulate the intestinal microbiota and may have beneficial effects on the immune response and anthropometric indices; however, the impact of the use of these supplements after bariatric sur